• 1
    White, J. M., ADAMs: modulators of cell–cell and cell–matrix interactions. Curr. Opin. Cell Biol. 2003. 15: 598606.
  • 2
    Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. et al., The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion. J. Biol. Chem. 2002. 277: 4821048219.
  • 3
    Fourie, A. M., Coles, F., Moreno, V. and Karlsson, L., Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 2003. 278: 3046930477.
  • 4
    Gómez-Gaviro, M., Domínguez-Luis, M., Canchado, J., Calafat, J., Janssen, H., Lara-Pezzi, E., Fourie, A. et al., Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J. Immunol. 2007. 178: 80538063.
  • 5
    Blobel, C., ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell. Biol. 2005. 6: 3243.
  • 6
    Koller, G., Schlomann, U., Golfi, P., Ferdous, T., Naus, S. and Bartsch, J. W., ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies. Curr. Pharm. Des. 2009. 15: 22722281.
  • 7
    Matsuno, O., Kumamoto, T. and Higuchi, Y., ADAM8 in allergy. Inflamm. Allergy Drug Targets 2008. 7: 108112.
  • 8
    Valkovskaya, N., Kayed, H., Felix, K., Hartmann, D., Giese, N., Osinsky, S., Friess, H. and Kleeff, J., ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J. Cell Mol. Med. 2007. 11: 11621174.
  • 9
    Harakawa, N., Shigeta, A., Wato, M., Merrill-Skoloff, G., Furie, B., Furie, B., Okazaki, T. et al., P-selectin glycoprotein ligand-1 mediates L-selectin-independent leukocyte rolling in high endothelial venules of peripheral lymph nodes. Int. Immunol. 2007. 19: 321329.
  • 10
    Sperandio, M., Smith, M., Forlow, S., Olson, T., Xia, L., McEver, R. and Ley, K., P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J. Exp. Med. 2003. 197: 13551363.
  • 11
    Urzainqui, A., Serrador, J. M., Viedma, F., Yanez-Mo, M., Rodriguez, A., Corbi, A. L., Alonso-Lebrero, J. L. et al., ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 2002. 17: 401412.
  • 12
    Urzainqui, A., Martínez del Hoyo, G., Lamana, A., de la Fuente, H., Barreiro, O., Olazabal, I., Martin, P. et al., Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J. Immunol. 2007. 179: 74577465.
  • 13
    Lichtenthaler, S., Dominguez, D., Westmeyer, G., Reiss, K., Haass, C., Saftig, P., De Strooper, B. and Seed, B., The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 2003. 278: 4871348719.
  • 14
    Ivetic, A. and Ridley, A., Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 2004. 112: 165176.
  • 15
    Davenpeck, K. L., Brummet, M. E., Hudson, S. A., Mayer, R. J. and Bochner, B. S., Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J. Immunol. 2000. 165: 27642772.
  • 16
    Stampfuss, J.-J., Censarek, P., Fischer, J. W., Kaber, G., Rauch, B. H., Freidel, K., Fischer, U. et al., Complete downmodulation of P-selectin glycoprotein ligand in monocytes undergoing apoptosis. Arterioscler. Thromb. Vasc. Biol. 2008. 28: 13751378.
  • 17
    Naus, S., Reipschläger, S., Wildeboer, D., Lichtenthaler, S., Mitterreite, S., Guan, Z., Moss, M. and Bartsch, J., Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol. Chem. 2006. 387: 337346.
  • 18
    Zack, M. D., Melton, M. A., Stock, J. L., Storer, C. E., Barve, R. A., Minnerly, J. C., Weiss, D. J. et al., Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8). Clin. Exp. Immunol. 2009. 158: 246256.
  • 19
    Barrero-Villar, M., Cabrero, J., Gordón-Alonso, M., Barroso-González, J., Alvarez-Losada, S., Muñoz-Fernández, M., Sánchez-Madrid, F. and Valenzuela-Fernández, A., Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. J. Cell Sci. 2009. 122: 103113.